Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Allen

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2024
Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020Ariana P Toepfer, Justin Z Amarin, Andrew J Spieker, et al.
Journal of Clinical Microbiology|November 6, 2024
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 <i>plus</i> test on nasal and nasopharyngeal swabsAlexander L Greninger, Allan Larcena, Amrish Patel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 16, 2025
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settingsErin McElvania, Deepa Rao, Alexander L Greninger, et al.
Annals of Internal Medicine|April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US PopulationsTalia Pindyck, Aron J Hall, Jacqueline E Tate, et al.
The Journal of Infectious Diseases|July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for deliverySpyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
Pediatrics|January 13, 2026
Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 PandemicOlla Hamdan, Justin Z Amarin, James W Antoon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2025
Respiratory Syncytial Virus Co-Detection With Other Respiratory Viruses Is Not Significantly Associated With Worse Clinical Outcomes Among Children Aged <2 Years: New Vaccine Surveillance Network, 2016-2020Justin Z Amarin, Ariana P Toepfer, Andrew J Spieker, et al.
Pediatrics|June 7, 2026
Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024Mary C Moran, Mary E Wikswo, Leila C Sahni, et al.
JAMA Network Open|October 22, 2025
Changes in Antiviral Prescribing for Children With Influenza in US Emergency DepartmentsTess Stopczynski, Olla Hamdan, Justin Z Amarin, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2024
Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020Ariana P Toepfer, Justin Z Amarin, Andrew J Spieker, et al.
Journal of Clinical Microbiology|November 6, 2024
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 <i>plus</i> test on nasal and nasopharyngeal swabsAlexander L Greninger, Allan Larcena, Amrish Patel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 16, 2025
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settingsErin McElvania, Deepa Rao, Alexander L Greninger, et al.
Annals of Internal Medicine|April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US PopulationsTalia Pindyck, Aron J Hall, Jacqueline E Tate, et al.
The Journal of Infectious Diseases|July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for deliverySpyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
Pediatrics|January 13, 2026
Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 PandemicOlla Hamdan, Justin Z Amarin, James W Antoon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2025
Respiratory Syncytial Virus Co-Detection With Other Respiratory Viruses Is Not Significantly Associated With Worse Clinical Outcomes Among Children Aged <2 Years: New Vaccine Surveillance Network, 2016-2020Justin Z Amarin, Ariana P Toepfer, Andrew J Spieker, et al.
Pediatrics|June 7, 2026
Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024Mary C Moran, Mary E Wikswo, Leila C Sahni, et al.
JAMA Network Open|October 22, 2025
Changes in Antiviral Prescribing for Children With Influenza in US Emergency DepartmentsTess Stopczynski, Olla Hamdan, Justin Z Amarin, et al.
Pageof 21